Wealthspire Advisors, L.P. - ALBANY MOLECULAR RESH INC ownership

ALBANY MOLECULAR RESH INC's ticker is AMRI and the CUSIP is 012423109. A total of 143 filers reported holding ALBANY MOLECULAR RESH INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
Wealthspire Advisors, L.P. ownership history of ALBANY MOLECULAR RESH INC
ValueSharesWeighting
Q1 2017$18,000
-76.0%
1,317
-67.0%
0.00%
-72.7%
Q4 2016$75,000
+11.9%
3,993
-1.4%
0.01%
+10.0%
Q3 2016$67,000
+39.6%
4,048
+12.9%
0.01%
+25.0%
Q2 2016$48,000
+29.7%
3,585
+50.1%
0.01%
+14.3%
Q1 2016$37,000
-11.9%
2,388
+11.7%
0.01%
-12.5%
Q4 2015$42,0002,1370.01%
Other shareholders
ALBANY MOLECULAR RESH INC shareholders Q1 2017
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 567,400$11,473,00012.05%
Permian Investment Partners, LP 1,875,650$37,926,0007.67%
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP 1,490,174$30,131,0002.57%
AMERICAN CAPITAL MANAGEMENT INC 993,280$20,084,0001.91%
Netols Asset Management, Inc. 387,471$7,835,0001.54%
RICE HALL JAMES & ASSOCIATES, LLC 1,158,759$23,430,0001.35%
Evercore Wealth Management, LLC 1,233,880$24,948,0001.13%
Visium Asset Management, LP 3,200,000$64,704,0000.92%
Granite Investment Partners, LLC 303,787$6,143,0000.57%
FRANKLIN STREET ADVISORS INC /NC 144,125$2,914,0000.52%
View complete list of ALBANY MOLECULAR RESH INC shareholders